View Clinical Trial (Medical Research Study)
Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED) - NCT00256399-44106(Clinical Trial 133263)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Cleveland |
|
State:
|
|
OH |
| Zip Code: |
|
44106 |
| Conditions: |
|
BPH - Erectile Dysfunction |
| Purpose: |
|
Uroxatral (alfuzosin) may not only help BPH symptoms but may also improve sexual function in
males with BPH and ED.
|
| Study summary: |
|
The study will consist of a 30 day screening/washout phase at the end of which qualified
subjects will be assigned to alfuzosin 10 mg tablets once a day. Subjects will be treated
for 90 days. The total duration of the study will be 120 days. |
| Criteria: |
|
Inclusion Criteria:
- Males 45-75 years of age
- Confirmed diagnosis of BPH/lower urinary tract symptoms (LUTS) and ED
- Men with steady partner and who agree to attempt sex once a week.
Exclusion Criteria:
- Prostate cancer
- Prostatitis
- Penile disease
- Cardiac co-morbidity
- Pre-existing co-morbid conditions
- History of sensitivity to the drug or similar drugs
- Enrollment in another clinical trial
- Impaired hepatic function
- Impaired renal function
- Mental conditions rendering subject unable to understand the study
- Subjects not likely to comply with protocol |
|
|
|
| Study is available at: |
|
University Hospitals of Cleveland
Cleveland, OH 44106
United States
Primary Contact:
Ann M Serenko, MS, RN
Email: ann.serenko@uhhs.com
Phone: 216-844-3515 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 21, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|